As a leader in heart valves for over 60 years, Edwards Lifesciences is dedicated to providing you a destination for the latest transcatheter heart valve information, tools, resources, and innovative solutions.

Edwards SAPIEN 3 Ultra RESILIA Valve

Introducing SAPIEN 3 Ultra valve, now powered by RESILIA tissue

SAPIEN 3 Ultra RESILIA valve takes TAVR even further with the potential to improve valve longevity and reduce reintervention.*† Building on the benefits of the SAPIEN 3 platform, SAPIEN 3 Ultra RESILIA valve features a proprietary calcium-blocking technology, the same tissue technology used in the #1 implanted surgical valve in the US, and is the only transcather heart valve (THV) with dry tissue storage.

Learn about SAPIEN 3 Ultra RESILIA valve

*No clinical data are available that evaluate the long-term impact of RESILIA tissue in patients.

RESILIA tissue tested against tissue from commercially available bovine pericardial valves from Edwards Lifesciences in a juvenile sheep model. Flameng, et al. J Thorac Cardiovasc Surg 2015;149:340-5.

Training and education programs

We offer training on the safe and effective use of our technology, and education programs designed to optimize procedures to better serve your patients.

Review tools

Access the resource library

The resource library contains the latest data, patient guides, best practices and additional materials to help you and your Heart Team stay current and well-informed.

Get TAVR Resources

ACC/AHA Guideline expands TAVR as a Class I recommendation

The ACC/AHA released key updates in their 2020 Guideline for Valvular Heart Disease, including recommendations for the treatment of severe symptomatic aortic stenosis and transcatheter valve repair/implantation for patients. Have these guidelines readily available for your team.

Your first-time valve choice today affects your patients' treatment options tomorrow1

As you expand TAVR to new patient populations, protecting the lifetime management of your patients becomes the new standard.

See the data

Medical information request

Edwards Lifesciences is committed to providing healthcare professionals with accurate, unbiased, and balanced evidence-based product information in order to support clinical decision-making and facilitate better patient outcomes.

Request Transcatheter Heart Valve Medical Information

Research and education grants

Through its educational and research grant programs, Edwards Lifesciences is committed to supporting independent programs that further clinical knowledge, scientific exchange, medical education and delivery of effective therapies for structural heart disease and critical care monitoring, and is further committed to supporting independent research in the area of valve science and hemodynamic monitoring in order to enhance scientific knowledge for the purpose of extending and enhancing human life.

Go to the Edwards Lifesciences Grant portal

Stay connected

Be the first to receive the latest news in transcatheter heart valves, including event announcements.

References:   1. De Backer O, Landes U, Fuchs A, et al. Coronary access after TAVR-in-TAVR as evaluated by multidetector computed tomography. JACC Cardiovasc Interv. 2020; 13(21):2528-2538.